Design, synthesis, and discovery of 5-piperazinyl-1,2,6,7-tetrahydro-5H-azepino[3,2,1-hi]indol-4-one derivatives: A novel series of mixed dopamine D2/D4 receptor antagonist

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 4, 2003, Pages 701-704

  Zhao, He ^a   Zhang, Xiaoyan ^a   Hodgetts, Kevin ^a   Thurkauf, Andrew ^a   Hammer, Jack ^a   Chandrasekhar, Jayaraman ^a   Kieltyka, Andrzej ^a   Brodbeck, Robbin ^a   Rachwal, Stanislaw ^a   Primus, Renee ^a   Manly, Charles ^a  

^a NEUROGEN CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 4 RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR BLOCKING AGENT; INDOLE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG DESIGN; DRUG SCREENING; STRUCTURE ACTIVITY RELATION;

EID: 0037293939     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(02)01056-9     Document Type: Article

References (8)

1. Reynolds G.P. Trends Pharmacol. Sci. 13:1992;116.
2. Kane J., Honigfeld G., Singer J., Meltzer H. Arch. Gen. Psychiatry. 45:1988;789.
3. Kane J., Honigfeld G., Singer J., Meltzer H. Psychopharmacol. Bull. 24:1988;62.
4. Kulagowski J.J., Patel S. Curr. Pharm. Des. 3:1997;355.
5. Faraci W.S., Zorn S.H., Sanner M.A., Fliri A. Curr. Opin. Chem. Biol. 2:1998;535.
6. Zhao H., Thurkauf A., He X., Hodgetts K., Zhang X., Rachwal S., Kover R.X., Hutchison A., Peterson J., Kieltyka A., Brodbeck R., Primus R., Wasley J. Bioorg. Med. Chem. Lett. 12:2002;3105.
7. Zhao H., He X., Thurkauf A., Hoffman D., Kieltyka A., Brodbeck R., Primus R., Wasley J. Bioorg. Med. Chem. Lett. 12:2002;3111.
8. Zhao H., Thurkauf K., Braun J., Brodbeck R., Kieltyka A. Bioorg. Med. Chem. Lett. 10:2000;2119.